Literature DB >> 20483780

Gender-specific expression of beta1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis.

Saurav Brahmachari1, Kalipada Pahan.   

Abstract

Susceptibility to multiple sclerosis is higher in females than males. However, the underlying mechanism behind this gender difference is poorly understood. Because the presence of neuroantigen-primed T cells in the CNS is necessary to initiate the neuroinflammatory cascade of multiple sclerosis, we first investigated how these T cells interacted with astroglia, major resident glial cells of the CNS. Interestingly, we found that myelin basic protein (MBP)-primed T cells from female and castrated male mice, but not from male mice, produced proinflammatory molecules, such as NO, IL-1beta, and IL-6 in astroglia, and these responses were purely via contact between T cells and astroglia. Because T cell:glia contact requires several integrin molecules, we examined the involvement of integrins in this process. Both alpha4 and beta1, subunits of VLA-4 integrin, were found to be necessary for T cell contact-induced generation of proinflammatory molecules in astroglia. Interestingly, the expression of beta1, but not alpha4, was absent in male MBP-primed T cells. In contrast, female and castrated male MBP-primed T cells expressed both alpha4 and beta1. Similarly, we also detected beta1 in spleen of normal young female, but not male, mice. Furthermore, we show that male sex hormones (testosterone and dihydrotestosterone), but not female sex hormones (estrogen and progesterone), were able to suppress the mRNA expression of beta1 in female MBP-primed T cells. These studies suggest that beta1, but not alpha4, integrin of VLA-4 is the sex-specific molecule on T cell surface, and that the presence or absence of beta1 determines gender-specific T cell contact-mediated glial activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483780      PMCID: PMC2922040          DOI: 10.4049/jimmunol.0804356

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Characterization of ameboid microglia isolated from developing mammalian brain.

Authors:  D Giulian; T J Baker
Journal:  J Neurosci       Date:  1986-08       Impact factor: 6.167

2.  Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice.

Authors:  E H Sato; H Ariga; D A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-07       Impact factor: 4.799

3.  Decreased 5alpha-dihydrotestosterone catabolism suppresses T lymphocyte functions in males after trauma-hemorrhage.

Authors:  Rui Zheng; T S Anantha Samy; Christian P Schneider; Loring W Rue; Kirby I Bland; Irshad H Chaudry
Journal:  Am J Physiol Cell Physiol       Date:  2002-06       Impact factor: 4.249

4.  Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system.

Authors:  Sandhya Subramanian; Agata Matejuk; Alex Zamora; Arthur A Vandenbark; Halina Offner
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 5.  Inflammation and degeneration in multiple sclerosis.

Authors:  W Brück; C Stadelmann
Journal:  Neurol Sci       Date:  2003-12       Impact factor: 3.307

6.  Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells.

Authors:  Subhajit Dasgupta; Malabendu Jana; Xiaojuan Liu; Kalipada Pahan
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

7.  Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

Authors:  Karen M Palaszynski; Hongbiao Liu; Kyi Kyi Loo; Rhonda R Voskuhl
Journal:  J Neuroimmunol       Date:  2004-04       Impact factor: 3.478

8.  Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.

Authors:  C Malmeström; S Haghighi; L Rosengren; O Andersen; J Lycke
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

9.  Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

Authors:  Karen M Palaszynski; Kyi Kyi Loo; Judith F Ashouri; Hong-biao Liu; Rhonda R Voskuhl
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

10.  Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

2.  Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys.

Authors:  Susanta Mondal; Suresh B Rangasamy; Avik Roy; Sridevi Dasarathy; Jeffrey H Kordower; Kalipada Pahan
Journal:  J Immunol       Date:  2019-05-01       Impact factor: 5.422

3.  Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson's Disease.

Authors:  Goutam Chandra; Avik Roy; Suresh B Rangasamy; Kalipada Pahan
Journal:  J Immunol       Date:  2017-04-26       Impact factor: 5.422

4.  Regulation of encephalitogenicity of neuroantigen-primed T cells by nitric oxide: Implications for multiple sclerosis.

Authors:  Susanta Mondal; Saurav Brahmachari; Kalipada Pahan
Journal:  J Clin Cell Immunol       Date:  2012-07-16

5.  Lower serum levels of Th2-related chemokine CCL22 in women patients with multiple sclerosis: a comparison between patients and healthy women.

Authors:  A Jafarzadeh; H A Ebrahimi; S Bagherzadeh; F Zarkesh; F Iranmanesh; A Najafzadeh; A Khosravimashizi; M Nemati; A Sabahi; H Hajghani; H Daneshvar; M M Mohammadi
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

6.  Immunomodulation of experimental allergic encephalomyelitis by cinnamon metabolite sodium benzoate.

Authors:  Kalipada Pahan
Journal:  Immunopharmacol Immunotoxicol       Date:  2011-03-22       Impact factor: 2.730

7.  Differential methylation of the gene encoding myo-inositol 3-phosphate synthase (Isyna1) in rat tissues.

Authors:  Ratnam S Seelan; M Michele Pisano; Robert M Greene; Manuel F Casanova; Ranga N Parthasarathy
Journal:  Epigenomics       Date:  2011-02       Impact factor: 4.778

8.  Multiple Sclerosis and Experimental Allergic Encephalomyelitis.

Authors:  Kalipada Pahan
Journal:  J Clin Cell Immunol       Date:  2013-09-23

9.  Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease.

Authors:  Goutam Chandra; Suresh B Rangasamy; Avik Roy; Jeffrey H Kordower; Kalipada Pahan
Journal:  J Biol Chem       Date:  2016-05-12       Impact factor: 5.157

10.  Myelin Basic Protein-primed T Helper 2 Cells Suppress Microglial Activation via AlphaVBeta3 Integrin: Implications for Multiple Sclerosis.

Authors:  Avik Roy; Kalipada Pahan
Journal:  J Clin Cell Immunol       Date:  2013-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.